gvtcx

Mpox vaccine (2024)

UK Health Security Agency Published 10 Oct 2024 Contracts Finder

key details

Statuscomplete
Category (CPV) 33651600
Deadline11 Sept 2024
Contract start12 Sept 2024
Contract end31 Dec 2027
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-82065fe9-b927-4701-82fd-422eb8954c2f

Award

SupplierValueDateStatus
Bavarian Nordic A/S £1 11 Sept 2024 active

description

A contract for a vaccine indicated for primary vaccination against smallpox, Mpox and disease caused by vaccinia virus in adults.

Delivery of more than 150,000 doses will be required over the initial term, with an option to extend for up to an additional 24 months.

Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
10 Oct 2024 Award (award) · 151e1989-8553-4e2c-8e97-0b13026ebd69-792923

more from UK Health Security Agency

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.